BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28463780)

  • 1. A novel liquid chromatography/tandem mass spectrometry (LC-MS/MS) based bioanalytical method for quantification of ethyl esters of Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) and its application in pharmacokinetic study.
    Viswanathan S; Verma PRP; Ganesan M; Manivannan J
    J Pharm Biomed Anal; 2017 Jul; 141():250-261. PubMed ID: 28463780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance.
    Maki KC; Johns C; Harris WS; Puder M; Freedman SD; Thorsteinsson T; Daak A; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):652-658. PubMed ID: 28189365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Salm P; Taylor PJ; Kostner K
    Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
    Krokan HE; Bjerve KS; Mørk E
    Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Separation of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester by simulated moving bed chromatography].
    Dong Q; Li M; Yang Y; Bao Z; Yang Q; Zhang Z; Ren Q
    Se Pu; 2018 Sep; 36(9):858-865. PubMed ID: 30251513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
    Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-APCI-MS/MS assay for quantitation of ethyl esters of eicosapentaenoic acid and docosahexaenoic acid in human plasma and its application in a pharmacokinetic study.
    Li L; Xia Y; Zhao S; Ding L; Ji S
    Biomed Chromatogr; 2020 Oct; 34(10):e4905. PubMed ID: 32449539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
    Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
    Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C; Maggi FM; Risé P; Sirtori CR
    Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of eicosapentaenoic and docosahexaenoic acid geometrical isomers formed during fish oil deodorization by gas-liquid chromatography.
    Fournier V; Destaillats F; Hug B; Golay PA; Joffre F; Juanéda P; Sémon E; Dionisi F; Lambelet P; Sébédio JL; Berdeaux O
    J Chromatogr A; 2007 Jun; 1154(1-2):353-9. PubMed ID: 17449039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
    Fialkow J
    Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults.
    Bremmell KE; Briskey D; Meola TR; Mallard A; Prestidge CA; Rao A
    Eur J Nutr; 2020 Sep; 59(6):2729-2737. PubMed ID: 31637467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed-Phase Medium-Pressure Liquid Chromatography Purification of Omega-3 Fatty Acid Ethyl Esters Using AQ-C18.
    Sang M; Pan N; Wu J; Chen X; Cai S; Fang H; Xiao M; Jiang X; Liu Z
    Mar Drugs; 2024 Jun; 22(6):. PubMed ID: 38921596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor
    Kang KM; Jeon SW; De A; Hong TS; Park YJ
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.